LOS ANGELES--(BUSINESS WIRE)--Guy A. Young, MD, a Children’s Hospital Los Angeles physician specializing in hematology-oncology, has been selected by the National Hemophilia Foundation to receive the Physician of the Year award.
“We are quite proud of Dr. Young’s accomplishments, leadership and work to help individuals with clotting disorders”
“We are quite proud of Dr. Young’s accomplishments, leadership and work to help individuals with clotting disorders,” said Alan S. Wayne, MD, director of the Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles and head of the Division of Hematology, Oncology, and Blood and Marrow Transplantation in the Department of Pediatrics at the Keck School of Medicine of the University of Southern California. “This award is a wonderful and well-deserved honor.”
The National Hemophilia Foundation seeks better treatments and cures for genetic bleeding disorders and aims to prevent the complications of these disorders through education and research. Hemophilia is an inheritable bleeding condition that thwarts the blood from clotting normally, leading to uncontrollable bleeding, a condition that affects an estimated 20,000 Americans.
Young, a resident of Hermosa Beach, came to Children’s Hospital in 2007 to head the hospital’s hemophilia program and develop a program in pediatric thrombosis, an abnormality in which the blood has an increased tendency to clot, the reverse of hemophilia.
Thrombosis is a very common medical problem. It is estimated that some two million Americans suffer from a deep vein thrombosis (DVT) episode each year, and that group includes children, adolescents and young adults. An estimated 600,000 Americans die from abnormal blood clots annually.
Young has an international reputation in thrombosis and hemostasis, the process of causing bleeding to stop. He also has continued to be very active at local, national and international levels in clinical research related to hemophilia and thrombotic disorders. He heads the hospital’s Hemostasis and Thrombosis Center and is an associate professor of Pediatrics at the Keck School of Medicine of the University of Southern California.
The Hemostasis and Thrombosis Program is a vital component of the CCCBD, which is one of the largest pediatric hematology-oncology programs in the United States and in 2013 was ranked 4th by the U.S. News & World Report.
Young earned his medical degree from State University of New York at Stony Brook and completed his internship at Schneider Children's Hospital at Long Island Jewish Medical Center, where he also earned his fellowship in pediatric hematology/oncology. He completed his residency at Children's National Medical Center in Washington D.C.
“Our research team is focused on improving treatment for patients with bleeding and clotting disorders,” he says. “Specifically, we are testing new drugs in children with hemophilia and new drugs for children with blood clots. In addition, we are evaluating a blood analysis device called a thromboelastogram to help predict the response to treatment in patients with hemophilia and to predict which patients are at highest risk for thrombosis.”
Young, who will be awarded at the National Hemophilia Foundation Annual Meeting on October 5, has resided in Hermosa Beach since 2000 where he coaches and plays soccer. He and his physician wife, Rima Jubran, MD, who also specializes in hematology-oncology, have two boys, Adam, 12 and Ben, 10.